Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of InventisBio.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
InventisBio
China Flag
Country
Country
China
Address
Address
1000 Zhangheng Road, Building 63, Pudong New District, Shanghai, China
Telephone
Telephone
+86-(0)21-5078-1209
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

D-0502 is an oral selective estrogen receptor degrader (SERD), which also acts as an estrogen receptor antagonist, with therapeutic potential for the treatment of hormone receptor positive breast cancer.


Lead Product(s): D-0502

Therapeutic Area: Oncology Product Name: D-0502

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: GL Ventures

Deal Size: $147.0 million Upfront Cash: Undisclosed

Deal Type: Series D Financing September 28, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY